| REVIEW ARTICLE |
|
| Year : 2010 | Volume
: 9
| Issue : 2 | Page : 55-61 |
|
|
Current management of Parkinson's disease
F Salawu1, A Olokoba2, A Danburam1
1 Neurology Unit, Department of Medicine, Federal Medical Centre, Yola, Nigeria
2 Department of Medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria
Correspondence Address:
F Salawu
Neurology Unit, Department of Medicine, Federal Medical Centre, Yola 640 001, Adamawa State
Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1596-3519.64743
|
|
|
Although Parkinson's disease (PD) is still incurable, a large number of different treatments have become available to improve the quality of life and physical and psychological morbidity, and its early treatment is of prime importance. This article reviews the current situation of PD. This review was based on a search of Medline, the Cochrane Database of Systemic Reviews, and citation lists of relevant publications. The subject headings and keywords used were Parkinson's disease and therapeutic advances. Only articles written in English were included.The management of PD has evolved rapidly over the last 10 years with the advent of new drugs and new classes of drugs, but the currently available treatment methods are all symptomatic ones. However, some of these may have marginal disease-modifying effects. Progress in manufacture of newer drugs has markedly improved the treatment of early PD; however, the management of advanced Parkinson's symptoms remains a challenge. Currently no treatment has been proven to slow the progression of PD. Although symptomatic therapy can provide benefit for many years, PD will eventually result in significant morbidity. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
